Medicine News and Research

RSS

U.S. officials probing payments by drug and device makers to doctors overseas

The New York Times reports that federal officials are investigating whether a dozen drug and device makers "made illegal payments to doctors and health officials in foreign countries." Although pharmaceutical companies routinely contract with doctors in the United States to be consultants, experts say the situation is more complex overseas because "in much of the rest of the world, doctors are government employees. And even consulting arrangements that would be considered routine in the United States might violate the Foreign Corrupt Practices Act, particularly if the payments are outsize or the arrangements are not disclosed to the governments.

16 Aug 2010

Adverse effects in childhood lead to immune impairment later in life

The emotional pains we suffer in childhood can lead to weakened immune systems later in life, according to a new study.Based on this new research, the amount of this immune impairment even enhances that caused by the stress of caregiving later in life."What happens in childhood really matters when it comes to your immune response in the latter part of your life," explained Janice Kiecolt-Glaser, professor of psychology and psychiatry at Ohio State University. She explained her work at the annual meeting of the American Psychological Association in San Diego.

16 Aug 2010

Scientists discover new signaling pathway to reduce tumour growth in glioblastoma multiforme

Malignant gliomas are the most common subtype of primary brain tumor - and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to prostate, the most aggressive form of malignant glioma, called a glioblastoma multiforme or GBM, has steadfastly defied advances in neurosurgery, radiation therapy and various conventional or novel drugs. But an international team of scientists, headed by researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine, reports in the August 15 issue of Genes & Development that they have discovered a new signaling pathway between GBM cells - one that, if ultimately blocked or disrupted, could significantly slow or reduce tumor growth and malignancy.

16 Aug 2010

Researchers discover genetic alterations responsible for Kabuki syndrome

Using a new, rapid and less expensive DNA sequencing strategy, scientists have discovered genetic alterations that account for most cases of Kabuki syndrome, a rare disorder that causes multiple birth defects and mental retardation. Instead of sequencing the entire human genome, the new approach sequences just the exome, the 1-2 percent of the human genome that contains protein-coding genes.

16 Aug 2010

CD31 positive cells have potential for treating peripheral artery disease: Research

Isolating cells from a patient's blood or bone marrow that nourish blood vessels may be a safer and less arduous route to treatment of cardiovascular disease than obtaining rare stem cells, according to research from Emory University School of Medicine. In recent clinical trials, doctors in several countries have tested the ability of a patient's bone marrow cells to repair damage, such as heart attacks and peripheral artery disease, created by problems of blood flow.

16 Aug 2010

Susan G. Komen for the Cure, OCNA urge FDA to allow use of Avastin

Susan G. Komen for the Cure and the Ovarian Cancer National Alliance today urged the U.S. Food and Drug Administration to continue to allow the use of the drug bevacizumab, commonly known as Avastin, for metastatic breast cancer patients, noting that it is effective for some patients and warning of a chilling effect on new drug development if approval is withdrawn.

13 Aug 2010

UT System Board of Regents approve plans for new University Hospital at UT Southwestern Medical Center

The UT System Board of Regents today gave its approval to plans for a new state-of-the-art University Hospital at UT Southwestern Medical Center in Dallas. The project now will go to the Texas Higher Education Coordinating Board for its review and final approval.

13 Aug 2010

Researchers identify second type of complete sporadic disease

A new sporadic prion protein disease has been discovered. Variably protease-sensitive prionopathy, as it has been named, is the second type of complete sporadic disease to be identified since Creutzfeldt-Jakob disease was reported in the 1920s. The landmark finding from the National Prion Disease Pathology Surveillance Center at Case Western Reserve University is published in the August issue of Annals of Neurology.

13 Aug 2010

ACAM, AAEM sign agreement to host joint conference in Portland

The American College for Advancement in Medicine and the American Academy of Environmental Medicine are excited to announce they have reached an agreement to host a joint conference and tradeshow, November 16 - 20, 2011 in Portland, Oregon.

13 Aug 2010

SANUWAVE second-quarter revenues decrease to $117,000

SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, today reported financial results for the three and six months ended June 30, 2010 and provided a business update.

13 Aug 2010

LabCorp announces collaboration between Esoterix Clinical Trials Services, Clearstone Central Laboratories

Laboratory Corporation of America Holdings announced today a collaboration between Esoterix Clinical Trials Services, a division of LabCorp, and Clearstone Central Laboratories, a global central laboratory specializing in drug development and pharmaceutical services.

13 Aug 2010

Catalyst second-quarter net loss decreases to $1,328,541

Catalyst Pharmaceutical Partners, Inc. today announced its financial results for the second quarter and six months ended June 30, 2010.

13 Aug 2010

CRF announces additional featured trials to be presented at Transcatheter Cardiovascular Therapeutics 2010

The Cardiovascular Research Foundation has announced that in addition to the previously announced late breaking clinical trials and first reports, a series of additional featured trials will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 scientific symposium. These trials will focus on a wide range of significant topics in interventional cardiovascular medicine. TCT 2010 will take place September 21 - 25 in Washington, DC.

13 Aug 2010

Pro-Pharmaceuticals second-quarter net loss applicable to common stock decreases to $2.5 million

Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the second quarter and the first six months ended June 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.

13 Aug 2010

National organization releases “Lessons from the Frontlines” report on H1N1

The Canadian Medical Association (CMA), the College of Family Physicians of Canada (CFPC), and the National Specialty Society of Community Medicine (NSSCM) today released Lessons from the Frontlines, a collaborative report on H1N1 describing the physician experience on the frontlines of the pandemic.

13 Aug 2010

UMass Memorial selects McKesson's CytoCare robot to automate compounding of hazardous IV drugs

UMass Memorial Medical Center in Massachusetts has selected the CytoCare™ robot from McKesson to automate the compounding of intravenous (IV) drugs. The robotic technology will enable the 830-bed facility to more safely prepare hazardous IVs, protecting both their patients and their staff from exposure risks.

13 Aug 2010

Research reveals self-care improves healing experience

New research conducted by Experience In Motion LLC (EIM), Minneapolis, reveals that when healthcare organizations, their staff and practitioners engage in self-care as an organizational strategy, it not only improves the healing experience for themselves and patients, but it also improves business measures.

13 Aug 2010

MedAssurant enters agreement with NCQA to develop new measures of healthcare quality

MedAssurant Inc., a leading provider of data-driven healthcare solutions, today announced that it has entered into a definitive agreement with the National Committee for Quality Assurance, the organization that maintains the Healthcare Effectiveness Data and Information Set (HEDIS ®)—the most widely used performance measurement tool in healthcare and a core component of the Medicare Star Rating system—to support the development of new measures of healthcare quality that NCQA is developing under a contract it has with the Centers for Medicare & Medicaid Services.

13 Aug 2010

Mount Sinai receives grant from NIH to continue research on food allergy

Mount Sinai School of Medicine today announced that the National Institutes of Health (NIH) has renewed its funding of the Consortium of Food Allergy Research (CoFAR), providing an additional $29.9 million toward genetic research and the prevention and treatment of food allergy. Mount Sinai is the primary research site for CoFAR, leading seven other institutions around the country.

13 Aug 2010

NewCardio second-quarter net loss decreases to $1.5 million

NewCardio, Inc., a cardiac diagnostic technology provider, today announced financial results for the second quarter ended June 30, 2010.

13 Aug 2010

Medicine News and Research

U.S. officials probing payments by drug and device makers to doctors overseas

Adverse effects in childhood lead to immune impairment later in life

Scientists discover new signaling pathway to reduce tumour growth in glioblastoma multiforme

Researchers discover genetic alterations responsible for Kabuki syndrome

CD31 positive cells have potential for treating peripheral artery disease: Research

Susan G. Komen for the Cure, OCNA urge FDA to allow use of Avastin

UT System Board of Regents approve plans for new University Hospital at UT Southwestern Medical Center

Researchers identify second type of complete sporadic disease

ACAM, AAEM sign agreement to host joint conference in Portland

SANUWAVE second-quarter revenues decrease to $117,000

LabCorp announces collaboration between Esoterix Clinical Trials Services, Clearstone Central Laboratories

Catalyst second-quarter net loss decreases to $1,328,541

CRF announces additional featured trials to be presented at Transcatheter Cardiovascular Therapeutics 2010

Pro-Pharmaceuticals second-quarter net loss applicable to common stock decreases to $2.5 million

National organization releases “Lessons from the Frontlines” report on H1N1

UMass Memorial selects McKesson's CytoCare robot to automate compounding of hazardous IV drugs

Research reveals self-care improves healing experience

MedAssurant enters agreement with NCQA to develop new measures of healthcare quality

Mount Sinai receives grant from NIH to continue research on food allergy

NewCardio second-quarter net loss decreases to $1.5 million

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News